Docosahexaenoic Acid-Driven Metabolic Reprogramming as an Attractive Anti-Infection Strategy to Potentiate β-Lactam Antibiotic Efficacy
The emergence and prevalence of methicillin-resistant Staphylococcus aureus (MRSA) severely compromises conventional β-lactam antibiotics efficacy and poses an extensive global health challenge. Given the close relationship between docosahexaenoic acid (DHA) and metabolic alterations, this study aim...
Saved in:
| Main Authors: | Lei Xu, Sangyu Hu, Yuzhu Pei, Yutong Zhou, Xiuli Zhang, Linlin Ding, Minhe Cui, Yonglin Zhou, Xuming Deng, Zihao Teng, Jianfeng Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association for the Advancement of Science (AAAS)
2025-01-01
|
| Series: | Research |
| Online Access: | https://spj.science.org/doi/10.34133/research.0650 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
β-Lactam/β-Lactamase Inhibitor Combination Antibiotics Under Development
by: Angeliki Katsarou, et al.
Published: (2025-02-01) -
Resensitizing β‐Lactams by Reprogramming Purine Metabolism in Small Colony Variant for Osteomyelitis Treatment
by: Tingwang Shi, et al.
Published: (2025-02-01) -
Conjugation of Polycationic Peptides Extends the Efficacy Spectrum of β‐Lactam Antibiotics
by: Julia Werner, et al.
Published: (2024-12-01) -
Phage Anti-Pycsar Proteins Efficiently Degrade β-Lactam Antibiotics
by: Pallav Joshi, et al.
Published: (2024-10-01) -
Beta‐Lactam Antibiotics Promote Extracellular Vesicle Production of Staphylococcus aureus Through ROS‐Mediated Lipid Metabolic Reprogramming
by: Xiaonan Huang, et al.
Published: (2025-05-01)